PureTech Health (PRTC) Equity Average (2020 - 2025)

PureTech Health (PRTC) has 6 years of Equity Average data on file, last reported at $344.0 million in Q4 2025.

• Equity Average for Q4 2025 came in at $344.0 million, down 5.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $344.0 million (down 5.82% YoY), and the FY2025 annual result was $363.4 million, down 17.3% from the prior year.
• Equity Average eased to $344.0 million in Q4 2025 per PRTC's latest filing, from $395.3 million in the prior quarter.
• Over five years, Equity Average peaked at $631.6 million in Q4 2021 and troughed at $344.0 million in Q4 2025.
• A 5-year average of $456.8 million and a median of $395.3 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2024 and 2025: Equity Average retreated 27.4% in 2024, then gained 1.38% in 2025.
• A 5-year view of Equity Average shows it stood at $631.6 million in 2021, then decreased by 10.1% to $567.9 million in 2022, then decreased by 11.4% to $503.1 million in 2023, then slipped by 27.4% to $365.3 million in 2024, then retreated by 5.82% to $344.0 million in 2025.
• Business Quant data shows PRTC's Equity Average at $344.0 million in Q4 2025, $395.3 million in Q2 2025, and $365.3 million in Q4 2024.